CLASS II Device recall · Reported 11 Oct 2023 · FDA Enforcement Report

Restore Clinician Programmer Application recalled

Medtronic Neuromodulation is recalling Restore Clinician Programmer Application, distributed nationwide in the US. The recall was initiated on 17 Jul 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesVersion 1.0.4232, UDI-DI 00763000273668.
Quantity recalled2,408 devices

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2657-2023
FDA event ID
92798
Recalling firm
Medtronic Neuromodulation, Minneapolis, MN
Classification
Class II
Status
Terminated
Recall initiated
17 Jul 2020
FDA classified
29 Sep 2023
Reported
11 Oct 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

17 Jul 2020Recall initiated by company
29 Sep 2023Classified by FDA+1169 days
11 Oct 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The original version of the A71100 Restore Clinician Programmer Application has been identified to have a compatibility issue with some legacy clinician programmer software resulting in the programmer having an inability to establish communication with the implanted neurostimulators.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Restore Clinician Programmer Application Software, model number A71100, used with the Restore Neurostimulators.

Where it was distributed

Worldwide distribution - US Nationwide (there was government and military distribution) and the countries of Australia and Singapore.

Nationwide

Questions about this recall

Is Restore Clinician Programmer Application recalled?

Yes. Medtronic Neuromodulation recalled Restore Clinician Programmer Application on 17 Jul 2020. The recall is Class II and its status is Terminated. Recall number Z-2657-2023.

Why was it recalled?

The original version of the A71100 Restore Clinician Programmer Application has been identified to have a compatibility issue with some legacy clinician programmer software resulting in the programmer having an inability to establish communication with the implanted neurostimulators.

Which lots are affected?

Version 1.0.4232, UDI-DI 00763000273668.

Where was it sold?

Worldwide distribution - US Nationwide (there was government and military distribution) and the countries of Australia and Singapore.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medtronic Neuromodulation

All 86

Other Medical Software recalls

All 903